Open a VIP account (an enterprise account with priority handling, 24/7 dedicated customer care, unlimited usage/users, help on formatting, standards, rules, regulations, policy compliance, etc., and ...
(IN BRIEF) Novartis has announced promising 96-week results from the Phase III ASC4FIRST trial, showcasing Scemblix® (asciminib) as a superior treatment for newly diagnosed Philadelphia ...
Analyst Martin Mölder takes a look at the positions of political parties in Estonia heading into the new year.
Sixteen EU countries asked the European Commission on Monday to propose a new law in the coming months on taxing tobacco in ...